Atlas Trials

Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLC

Clinical trial NCT05441566 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05441566
Sponsor
Shenzhen People's Hospital
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
NSCLC MRD ctDNA
Start date
2022-06-01
Primary completion
2026-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.